Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 2053-2057, April 1, 2008. doi: 10.1158/0008-5472.CAN-07-2091
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Tabori, U.
Right arrow Articles by Malkin, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tabori, U.
Right arrow Articles by Malkin, D.
Related Collections
Right arrow Epidemiology and Prevention: Genetics and Biomarkers
Right arrow Clinical Research
Right arrow Clinical Research: Imaging, Diagnosis, and Prognosis

Reviews

Risk Stratification in Cancer Predisposition Syndromes: Lessons Learned from Novel Molecular Developments in Li-Fraumeni Syndrome

Uri Tabori1 and David Malkin1,2

1 Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children and 2 Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada

Requests for reprints: David Malkin, Division of Hematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8. Phone: 416-813-5348; Fax: 416-813-5327; E-mail: david.malkin{at}sickkids.ca.

Key Words: Cancer predisposition, risk, telomere, genetic modifier • Predictive assays for carcinogenicity • DNA damage and repair mechanisms • Risk assessment • p53

Germ-line mutations in specific genes predispose family members to cancer. Prediction of the exact tumor type and timing of cancer initiation is fundamental to the development of management strategies for these individuals. Recent advances in our understanding of the general processes that control cancer initiation may enable us to tailor more precise risk stratification. This, in turn, will lead to more effective early detection strategies, which would result in more favorable clinical outcomes. In this review, we highlight the steps and methods used to reach this futuristic model. [Cancer Res 2008;68(7):2053–7]




This article has been cited by other articles:


Home page
CRO ContentHome page
G. C. Prendergast
Risk Factors for Cancer: From Cell to Microenvironment
Cancer Reviews Online Content, May 1, 2008; 2008(5): 9 - 9.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.